Donanemab

4 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Donanemab
Treatment and conditionWhere it standsTrials
Donanemab for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)10
Donanemab for cognitive dysfunctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)5
Donanemab for down syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Donanemab for lewy body diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1